Marshall Wace
VAXX

Marshall Wace’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Marshall Wace’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-178,258
Closed -$352K – 3567
2022
Q3 		$352K Sell
178,258
-442,201
-71% -$920K ﹤0.01% 2886
2022
Q2 		$973K Buy
+620,459
New +$2.35M ﹤0.01% 2454

Other funds holding VAXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Marshall Wace's VAXX Position: Q4 2022 in Review

Marshall Wace sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q4 2022, closing a stake of 178,258 shares — an estimated $352K sold.

Marshall Wace first reported a position in VAXX in Q2 2022 and held it in 2 quarters. The position peaked at $973K in Q2 2022. 30 funds tracked by Wall St. Rank hold VAXX as of Q4 2022.

  • Marshall Wace reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Marshall Wace sold 178,258 Vaxxinity, Inc. Class A Common Stock shares in Q4 2022, an estimated $352K.
  • Marshall Wace first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2022 and held it in 2 quarters.
  • Marshall Wace's Vaxxinity, Inc. Class A Common Stock position peaked at $973K in Q2 2022.
  • 30 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q4 2022.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.